1 Children's Hospital, Harvard Medical School, Boston
2 Boston City Hospital, Boston University School of Medicine
3 Boston University School of Public Health
Objective. To determine in a representative sample of full-term urban newborns of English-speaking mothers whether an immediate or late dose-response effect could be demonstrated between prenatal cocaine exposure and newborn neurobehavioral performance, controlling for confounding factors.
Methods. The Neonatal Behavioral Assessment Scale (NBAS) was administered by masked examiners to a total sample of 251 clinically healthy, full-term infants at 2 days and/or 17 days. Three in utero cocaine exposure groups were defined: heavily exposed (n = 44, >75th percentile self-reported days of use during pregnancy and/or >75th percentile of meconium benzoylecognine concentration); lightly exposed (n = 79, less than both 75th percentiles); and unexposed (n = 101, no positive biological or self-report marker). At the 3-week examination there were 38 heavily exposed, 73 lightly exposed, and 94 unexposed infants. Controlling for infant birth weight, gestational age, infant age at the time of examination, mothers' age, perinatal risk, obstetric medication, and alcohol, marijuana, and cigarette use, a regression analysis evaluated the effects of levels of cocaine exposure on NBAS performance.
Results. No neurobehavioral effects of exposure on the newborn NBAS cluster scores or on the qualifier scores were found when confounders were controlled for at 2 to 3 days of age. At 3 weeks, after controlling for covariates, a significant dose effect was observed, with heavily exposed infants showing poorer state regulation and greater excitability.
Conclusions. These findings demonstrate specific dose-related effects of cocaine on 3-week neurobehavioral performance, particularly for the regulation of arousal, which was not observed in the first few days of life.
Submitted on June 27, 1995
This article has been cited by other articles:
![]() |
M. Beeghly, B. Martin, R. Rose-Jacobs, H. Cabral, T. Heeren, M. Augustyn, D. Bellinger, and D. A. Frank Prenatal Cocaine Exposure and Children's Language Functioning at 6 and 9.5 Years: Moderating Effects of Child Age, Birthweight, and Gender J. Pediatr. Psychol., January 1, 2006; 31(1): 98 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Morrow, A. L. Vogel, J. C. Anthony, A. Y. Ofir, A. T. Dausa, and E. S. Bandstra Expressive and Receptive Language Functioning in Preschool Children With Prenatal Cocaine Exposure J. Pediatr. Psychol., October 1, 2004; 29(7): 543 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohgi, T. Takahashi, J. K. Nugent, K. Arisawa, and T. Akiyama Neonatal Behavioral Characteristics and Later Behavioral Problems Clinical Pediatrics, October 1, 2003; 42(8): 679 - 686. [Abstract] [PDF] |
||||
![]() |
A. M. Butz, M. B. Pulsifer, M. Leppert, S. Rimrodt, and H. Belcher Comparison of Intelligence, School Readiness Skills, and Attention in In-Utero Drug-Exposed and Nonexposed Preschool Children Clinical Pediatrics, October 1, 2003; 42(8): 727 - 739. [Abstract] [PDF] |
||||
![]() |
D. A. Frank, R. R. Jacobs, M. Beeghly, M. Augustyn, D. Bellinger, H. Cabral, and T. Heeren Level of Prenatal Cocaine Exposure and Scores on the Bayley Scales of Infant Development: Modifying Effects of Caregiver, Early Intervention, and Birth Weight Pediatrics, December 1, 2002; 110(6): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Lester, E. Z. Tronick, L. LaGasse, R. Seifer, C. R. Bauer, S. Shankaran, H. S. Bada, L. L. Wright, V. L. Smeriglio, J. Lu, et al. The Maternal Lifestyle Study: Effects of Substance Exposure During Pregnancy on Neurodevelopmental Outcome in 1-Month-Old Infants Pediatrics, December 1, 2002; 110(6): 1182 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
H S Bada, C R Bauer, S Shankaran, B Lester, L L Wright, A Das, K Poole, V L Smeriglio, L P Finnegan, and P L Maza Central and autonomic system signs with in utero drug exposure Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2002; 87(2): F106 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Augustyn, D. A. Frank, M. Posner, and B. Zuckerman Children Who Witness Violence, and Parent Report of Children's Behavior Arch Pediatr Adolesc Med, August 1, 2002; 156(8): 800 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Millichap Prenatal Cocaine Exposure and Infantile Cognitive Outcome AAP Grand Rounds, July 1, 2002; 8(1): 10 - 11. [Full Text] [PDF] |
||||
![]() |
C. Macmillan, L.S. Magder, P. Brouwers, C. Chase, J. Hittelman, T. Lasky, K. Malee, C.A. Mellins, and J. Velez-Borras Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women Neurology, October 23, 2001; 57(8): 1402 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Butz, M. Pulsifer, N. Marano, H. Belcher, M. K. Lears, and R. Royall Effectiveness of a Home Intervention for Perceived Child Behavioral Problems and Parenting Stress in Children With In Utero Drug Exposure Arch Pediatr Adolesc Med, September 1, 2001; 155(9): 1029 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Singer, R. Arendt, S. Minnes, A. Salvator, A. C. Siegel, and B. A. Lewis Developing Language Skills of Cocaine-Exposed Infants Pediatrics, May 1, 2001; 107(5): 1057 - 1064. [Abstract] [Full Text] |
||||
![]() |
D. A. Frank, M. Augustyn, W. G. Knight, T. Pell, and B. Zuckerman Growth, Development, and Behavior in Early Childhood Following Prenatal Cocaine Exposure: A Systematic Review JAMA, March 28, 2001; 285(12): 1613 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Delaney-Black, C. Covington, T. Templin, J. Ager, B. Nordstrom-Klee, S. Martier, L. Leddick, R. H. Czerwinski, and R. J. Sokol Teacher-Assessed Behavior of Children Prenatally Exposed to Cocaine Pediatrics, October 1, 2000; 106(4): 782 - 791. [Abstract] [Full Text] |
||||
![]() |
S. M. Potter, P. R. Zelazo, D. M. Stack, and A. N. Papageorgiou Adverse Effects of Fetal Cocaine Exposure on Neonatal Auditory Information Processing Pediatrics, March 1, 2000; 105(3): 40e - 40. [Abstract] [Full Text] |
||||
![]() |
D. A. Frank, K. M. McCarten, C. D. Robson, M. Mirochnick, H. Cabral, H. Park, and B. Zuckerman Level of In Utero Cocaine Exposure and Neonatal Ultrasound Findings Pediatrics, November 1, 1999; 104(5): 1101 - 1105. [Abstract] [Full Text] |
||||
![]() |
Y. Fang and O. K. Ronnekleiv Cocaine Upregulates the Dopamine Transporter in Fetal Rhesus Monkey Brain J. Neurosci., October 15, 1999; 19(20): 8966 - 8978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chiriboga, J. C. M. Brust, D. Bateman, and W. A. Hauser Dose-Response Effect of Fetal Cocaine Exposure on Newborn Neurologic Function Pediatrics, January 1, 1999; 103(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Needlman, D. A. Frank, H. Cabral, M. Mirochnick, C. Kwon, and B. Zuckerman Blood Pressure in Children Exposed Prenatally to Cocaine Clinical Pediatrics, November 1, 1998; 37(11): 659 - 664. [Abstract] [PDF] |
||||
![]() |
V. Delaney-Black, C. Covington, T. Templin, J. Ager, S. Martier, and R. Sokol Prenatal Cocaine Exposure and Child Behavior Pediatrics, October 1, 1998; 102(4): 945 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. FRANK, M. AUGUSTYN, and B. S. ZUCKERMAN Neonatal Neurobehavioral and Neuroanatomic Correlates of Prenatal Cocaine Exposure: Problems of Dose and Confounding Ann. N.Y. Acad. Sci., June 21, 1998; 846(1): 40 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. CHIRIBOGA Neurological Correlates of Fetal Cocaine Exposure Ann. N.Y. Acad. Sci., June 21, 1998; 846(1): 109 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. GABRIEL and C. TAYLOR Prenatal Exposure to Cocaine Impairs Neuronal Coding of Attention and Discriminative Learning Ann. N.Y. Acad. Sci., June 21, 1998; 846(1): 194 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mirochnick, J. Meyer, D. A. Frank, H. Cabral, E. Z. Tronick, and B. Zuckerman Elevated Plasma Norepinephrine After In Utero Exposure to Cocaine and Marijuana Pediatrics, April 1, 1997; 99(4): 555 - 559. [Abstract] [Full Text] [PDF] |
||||